コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 h Salmonella enterica serovar Typhimurium (S Typhimurium).
2 erichia coli and Salmonella enterica serovar Typhimurium).
3 hila, Pseudomonas aeruginosa, and Salmonella typhimurium.
4 ty of Zur, ZntR, RcnR and FrmR in Salmonella Typhimurium.
5 e model pathogen Salmonella enterica serovar Typhimurium.
6 bic expansion of Salmonella enterica serovar Typhimurium.
7 ompared to that of the nontyphoidal serovarS Typhimurium.
8 including in the enteric pathogen Salmonella typhimurium.
9 ainst the drug-resistant bacteria Salmonella typhimurium.
10 munoassay of Escherichia coli and Salmonella typhimurium.
11 serotypes Enteritidis, Javiana, Panama, and Typhimurium.
12 n and exhibit increased susceptibility to S. Typhimurium.
13 l biosensor suitable for the detection of S. Typhimurium.
14 know the concentration of serovar Salmonella typhimurium.
15 oducing Klebsiella pneumoniae and Salmonella typhimurium.
16 ic separation (IMS) for detecting Salmonella typhimurium.
17 enzae, and Salmonella enterica serovar Typhi/Typhimurium.
18 ing infection withSalmonella entericaserovar Typhimurium.
19 ) compared to infections with S. Hadar or S. Typhimurium.
20 ellular pathogen Salmonella enterica serovar Typhimurium.
21 thogens, Francisella novicida and Salmonella typhimurium.
22 iving MET-1 or control, then gavaged with S. typhimurium.
23 ed at significantly lowers levels than in S. Typhimurium.
24 gen-CRM197 glycoconjugate vaccine against S. Typhimurium.
25 Enteritidis and 152 (43.3%) were Salmonella Typhimurium.
26 mucosa of mice infected with DsRed-labeled S typhimurium.
27 nvasive pathogen Salmonella enterica serovar Typhimurium.
28 ared with enterocolitis-causing strains of S Typhimurium.
29 s from Salmonella Choleraesuis in Salmonella Typhimurium.
30 particularly E. coli and Salmonella enterica Typhimurium.
31 t conducive to the intracellular growth of S Typhimurium.
32 s with the intracellular pathogen Salmonella typhimurium.
33 om primary human monocytes in response to S. typhimurium.
34 s, 40% (41) were Salmonella enterica serovar Typhimurium, 10% (10) were Salmonella enterica serovar E
36 other foodborne pathogens such as Salmonella Typhimurium, (7%) Listeria monocytogenes (3%) and Escher
40 uccumb to systemic infection with Salmonella Typhimurium, a pathogenic bacterium that multiplies with
43 6.1%), of which 8017 (79.1%) were Salmonella Typhimurium and 1608 (15.8%) were Salmonella Enteritidis
45 in S. Paratyphi A that does not occur in S. Typhimurium and demonstrate curious distinctions in moti
46 periplasmic globular domain of PbgA from S. typhimurium and E. coli, which revealed that the globula
47 ), particularly Salmonella enterica serovars Typhimurium and Enteritidis, is responsible for a major
50 8 in response to NLRC4 activators Salmonella Typhimurium and flagellin, canonical or non-canonical NL
55 esting Shigella, Salmonella spp., Salmonella typhimurium and Staphylococcus aureus on E. coli specifi
58 o flagellins from Salmonella typhimurium (S. typhimurium) and Bacillus subtilis (B. subtilis) were ex
59 y modified nonhalotolerant cells (Salmonella typhimurium) and dead vs. live differentiation of nonhal
61 intestinalis, Ruminococcus obeum, Salmonella typhimurium, and Clostridium difficile) to quantify, exp
62 endai are all noticeably less motile than S. Typhimurium, and comparative transcriptome sequencing (R
63 in vitro grown S. Typhi, S. Paratyphi A, S. Typhimurium, and E. coli were used to confirm the specif
64 rial pathogens (Escherichia coli, Salmonella typhimurium, and methicillin-resistant Staphylococcus au
65 ng latex beads, Escherichia coli, Salmonella typhimurium, and Mycobacterium tuberculosis in human and
66 etection of model food pathogens, Salmonella typhimurium, and Staphylococcus aureus, in which the flu
67 ane vesicles (OMVs) isolated from Salmonella Typhimurium are potentially useful for developing subuni
68 3SS and fT3SS of Salmonella enterica serovar Typhimurium at ~5 and ~4 nm resolution using electron cr
69 ecies, Pseudomonas putida KT2440, Salmonella Typhimurium ATCC 14028, Staphylococcus epidermidis ATCC
70 ected epithelial cells, a subpopulation of S Typhimurium bacteria damage their internalization vacuol
71 viral nanocontainer based on the Salmonella typhimurium bacteriophage P22 capsid, genetically incorp
72 ceptible to systemic infection by Salmonella Typhimurium because of loss-of-function mutations in Nra
73 d-borne pathogen Salmonella enterica serovar Typhimurium benefits from acute inflammation in part by
74 njugate vaccines against invasive African S. Typhimurium can have profound effects on immunogenicity
76 Most lineages of the S. enterica subspecies Typhimurium cause gastroenteritis in humans; however, th
79 llular bacterium Salmonella enterica serovar Typhimurium causes persistent systemic inflammatory dise
80 h as that mediated by l-asparaginase II of S Typhimurium causes suppression of activation-induced T c
81 samples were spiked with standard Salmonella typhimurium cells, and detection was done by measuring t
83 ability to kill Salmonella enterica serovar Typhimurium compared to that of macrophages isolated fro
84 T313 pathovar of Salmonella enterica serovar Typhimurium contributes to a high burden of invasive dis
86 nstrate that the Salmonella enterica serovar Typhimurium core promoter is more active than previously
88 atory response induced by Salmonella serovar Typhimurium creates a favorable niche for this gut patho
92 gesting that cytokinesis failure caused by S Typhimurium delays epithelial cell turnover in the intes
93 introduced into three constructed Salmonella Typhimurium Deltaasd mutants: SLT11 (DeltarfbP), SLT12 (
96 cles (OMVs) from Salmonella enterica serovar Typhimurium displaying the variable N terminus of PspA (
99 inoculated Enterococcus spp. and Salmonella typhimurium during the drying of struvite under controll
102 monella enterica subspecies enterica serovar Typhimurium employs a dedicated mechanism, driven by the
104 al replication, its administration reduced S Typhimurium epithelial cell invasion and lowered the ind
107 tudy showed that Salmonella enterica serovar Typhimurium exhibits sliding motility under magnesium-li
111 phosphorylation, whereas deletion of the S. Typhimurium flagellin carboxy-terminus prevented caspase
112 isolated Salmonella, 34.50% was confirmed S. Typhimurium, followed by S. Heidelberg (10.86%) and S. E
114 creen mutants of Salmonella enterica serovar Typhimurium for their ability to infect and grow in the
118 to immune serum identified a repertoire of S Typhimurium genes that, when interrupted, result in incr
121 ore genes within Salmonella enterica serovar Typhimurium genomes reveals a high degree of allelic var
123 r serovars of Salmonella enterica, Typhi and Typhimurium, have evolved a two-component regulatory sys
124 f a small heat shock protein from Salmonella typhimurium in a dimeric form and two higher oligomeric
128 sed platform was applied for detection of S. typhimurium in inoculated Starling bird fecal samples an
132 ated its suitability for the detection of S. typhimurium in spiked (1 x 10(2), 1 x 10(4) and 1 x 10(6
133 unosensor was able to specifically detect S. typhimurium in spiked water and juice samples with a sen
137 ES cell-derived macrophages responded to S. Typhimurium, in a comparable manner to mouse bone marrow
138 SPI-1 expression between S. Paratyphi A andS Typhimurium, indicate that S. Paratyphi A host cell inva
139 at intracellular Salmonella enterica serovar Typhimurium induced the binucleation of a large proporti
143 iently attenuate Salmonella enterica serovar Typhimurium-induced pyroptosis and proinflammatory cytok
145 model of sepsis, we observed that Salmonella typhimurium-infected mice exhibited simultaneous impaire
147 and host during Salmonella enterica serovar Typhimurium infection and reveal the molecular impact of
150 ity of disease induced by enteric Salmonella Typhimurium infection is strongly modulated by microbiot
154 f2 function and antioxidative responses to S Typhimurium infection, eventually leading to cell death.
155 uppressed during Salmonella enterica serovar Typhimurium infection, facilitating increased IL-1beta p
161 y Salmonella enterica serovar Typhimurium (S Typhimurium) inhibits T cell responses and mediates viru
162 port that an intestinal pathogen, Salmonella Typhimurium, inhibits anorexia by manipulating the gut-b
163 ted with PBA exhibited significantly lower S Typhimurium intestinal colonization and dissemination to
164 standard DNA and 10(1) copies of Salmonella typhimurium InvA gene sequences (cloned in E. coli and a
170 ne resistance of Salmonella enterica serovar Typhimurium is attributed to the high-molecular-weight L
172 lls, in which growth of cytosolic Salmonella Typhimurium is inhibited independently or prior to the o
174 ism of FrmR from Salmonella enterica serovar Typhimurium is triggered by metals in vitro, and variant
176 gative bacterium, Salmonella Typhimurium (S. Typhimurium) is a food borne pathogen responsible for nu
177 s between this lineage and other non-iNTS S. Typhimurium isolates is the presence of prophage BTP1.
178 resistance was noted in 12.7% of Salmonella Typhimurium isolates, appearing in Bas-Congo from 2013 o
179 ease SPI-6 antibacterial activity and that S Typhimurium kills commensal bacteria in a T6SS-dependent
180 ined that, in a murine model of infection, S Typhimurium lacking both l-asparaginase I and II genes c
181 t in the closely related S. enterica serovar Typhimurium LT2 and from a mutant of S Montevideo, each
183 E. coli O157:H7, Salmonella enterica serovar Typhimurium LT2, Staphylococcus aureus, and Streptococcu
186 lly found on the Salmonella enetrica serovar Typhimurium multi-resistance plasmid pMG101 from burns p
187 racellular infectious cycle, we screened a S Typhimurium multigene deletion library in Caco-2 C2Bbe1
188 , but avirulent, Salmonella enterica serovar Typhimurium mutant for its ability to compete with wild-
193 nvestigate the impact of coupling Salmonella typhimurium O-antigen to different amino acids of CRM197
194 actericidal activity can be influenced by S. Typhimurium OAg strain, most likely as a result of diffe
195 is study was to investigate the effect of S. typhimurium on inflammasomes in primary human monocytes.
201 coli (EHEC) and Salmonella enterica serovar Typhimurium, or the surrogate murine infection model for
202 with IBS, larger numbers of E coli HS and S typhimurium passed through the epithelium than in biopsi
203 the prototypical Salmonella enterica serovar Typhimurium pathogenicity island 1 basal body, determine
204 oid from Scutellaria baicalensis, targets S. Typhimurium pathogenicity island-1 (SPI-1) type III secr
205 rug resistant, whereas a dominant Salmonella Typhimurium pathotype, ST313, was primarily associated w
206 deficient CX3CR1(-/-) mice the numbers of S. Typhimurium penetrating the epithelium were significantl
211 a detection limit of 10(2) CFU mL(-1) for S. typhimurium, providing an instrument-free quantitative a
212 scherichia coli, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Bacillus subtilis,
215 4.8; 95% CI, 1.1-21.1; P = .039).Salmonella Typhimurium represented 106 of 238 (44.5%) serotyped iso
216 ogenic bacterium Salmonella enterica serovar Typhimurium requires a T6SS encoded within Salmonella pa
218 e II produced by Salmonella enterica serovar Typhimurium (S Typhimurium) inhibits T cell responses an
222 dent exposures to flagellins from Salmonella typhimurium (S. typhimurium) and Bacillus subtilis (B. s
223 The Gram-negative bacterium, Salmonella Typhimurium (S. Typhimurium) is a food borne pathogen re
225 Salmonella (Salmonella enterica serovar Typhimurium) secrete numerous effector proteins, includi
226 antigen extraction was done from Salmonella typhimurium serovars, under the optimized growth conditi
230 we show that infection of host cells with S Typhimurium specifically induces the ubiquitination of t
232 e catalytic triad, is variable, with serovar Typhimurium SpvD having an arginine and serovar Enteriti
234 ections of Gram-negative Salmonella enterica Typhimurium (ST), a major source of human food poisoning
236 abbits were orally infected with S. enterica Typhimurium strain chi3987 harboring phagemid NgoPhi6 fm
238 nomes of S. enterica subsp. enterica serovar Typhimurium strain LT2 and Salmonella bongori strain 124
240 not affect Ab responses to a noninvasive S. Typhimurium strain that specifically targeted the CX3CR1
244 ne secretion by S. Paratyphi A but not by S. Typhimurium, suggesting that SPI-1 expression is natural
246 r results reveal a novel strategy in which S Typhimurium T3SS effectors broaden their functions throu
247 w that human NAIP also senses the Salmonella Typhimurium T3SS inner rod protein PrgJ and that T3SS in
250 induced mutagenicity (26%) in the Salmonella typhimurium TA102 strain, as determined by the Ames test
254 activity against Salmonella enterica serovar Typhimurium that is not shared by the related purine met
255 y labeled Escherichia coli HS and Salmonella typhimurium that passed through from the mucosal side to
256 together with l-asparaginase I to provide S Typhimurium the ability to catabolize asparagine and ass
257 genes, Pseudomonas aeruginosa and Salmonella Typhimurium The geranylated residues are located in the
258 tested for efficacy only against Salmonella Typhimurium, the modified Salmonella strain may be able
259 ions, strains of Salmonella enterica serovar Typhimurium, the murine model of S Typhi, in which vario
260 ne expression during infection by Salmonella typhimurium This occurred in the first 3 d of infection,
262 the response of Salmonella enterica serovar Typhimurium to diverse environmental challenges encounte
263 isotypes specific for the O:4 antigen of S. Typhimurium to effect in vitro and in vivo killing of th
265 ing transposon insertion mutant library of S Typhimurium to immune serum identified a repertoire of S
266 d the ability of Salmonella enterica serovar Typhimurium to infect the central nervous system and cau
267 amily members of Salmonella enterica serovar Typhimurium to link the constitutively expressed CspC an
270 In order to assess the ability of Salmonella Typhimurium to replicate in human macrophages, we infect
274 ntracellular pathogens, including Salmonella typhimurium, trigger autophagy in host cells, which is w
275 e killing of Escherichia coli and Salmonella typhimurium, two common pathogens, at levels 10- to 20-t
276 solution in situ structure of the Salmonella Typhimurium type III secretion machine obtained by high-
278 estinal pathogen Salmonella enterica serovar Typhimurium uses specialized metal transporters to evade
280 that asparagine catabolism contributes to S Typhimurium virulence, providing new insights into the c
281 Infection of DR3(-/-) mice with Salmonella typhimurium was associated with defective microbial clea
282 ng this system, the limit of detection of S. typhimurium was found to be 10(2) CFU mL(-1) in culturin
285 ver, in these mice the number of invading S. Typhimurium was significantly reduced after the adoptive
287 ein secretion in Salmonella enterica serovar Typhimurium, we discovered that several TCMs can attenua
289 of designing an effective vaccine against S. Typhimurium, we have synthesized different glycoconjugat
291 hin 1 hour, greater numbers of T gondii or S typhimurium were present within mucosae of mice with mig
293 cytogenes V7 and Salmonella enterica serovar Typhimurium were used as model pathogens to evaluate the
294 nse to the intracellular pathogen Salmonella typhimurium, which can disrupt metabolism by uptake of h
295 he phagosome mediates host defense against S Typhimurium, which is counteracted by copper export from
297 a direct label-free detection of Salmonella Typhimurium with the limit of detection (LOD) of 10(4) C
298 used to capture a food pathogen, Salmonella typhimurium, with starting concentrations as low as 10(
299 od was confirmed to be highly specific to S. typhimurium without interference from other pathogenic b
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。